May 6, 2026

Salk Institute welcomes Sarah Wolf Hallac to Board of Trustees

Noticias del Instituto Salk


Salk Institute welcomes Sarah Wolf Hallac to Board of Trustees

LA JOLLA—Sarah Wolf Hallac has been appointed to the Salk Institute’s Consejo de Administración. She brings broad experience spanning technology, finance, and philanthropy and will help guide the Institute as it advances foundational science that fuels future breakthroughs.

Sarah Wolf Hallac joins the Salk Institute’s Board of Trustees.
Sarah Wolf Hallac joins the Salk Institute’s Board of Trustees.

Hallac is an advisor to VectoIQ and a director of VectoIQ acquisition corporation, a company that partners with startups and early-stage companies to develop next-generation smart transportation products and services, including autonomous vehicles, wireless vehicle charging, and fleet management solutions. She is also a consultant to BlackRock on significant philanthropic projects. Earlier in her career, Hallac was an investment banker at Bear, Stearns and Company, where she spent her tenure in the Financial Analytics and Structured Transaction Group.

“Sarah will bring thoughtful leadership to our Board at an important moment for science,” says Salk President Dr. Gerald Joyce, médico y doctor en Medicina. “She understands that enduring discovery depends on strong institutions, and that makes her an exceptional addition to Salk.”

Hallac is a member of the Board of Advisors for Georgia Tech and the School of Engineering at the University of Pennsylvania. She also serves on the Board of Directors of Centro Primo Levi, a New York-based organization inspired by the humanistic legacy of writer and chemist Primo Levi.

Hallac earned a BSE in electrical engineering and a BS in economics from the University of Pennsylvania.

Para más información

Oficina de Comunicaciones
Tel.: (858) 453-4100
press@salk.edu

El Instituto Salk de Estudios Biológicos:

El Instituto Salk es un centro de investigación independiente y sin fines de lucro fundado en 1960 por Jonas Salk, creador de la primera vacuna segura y eficaz contra la poliomielitis. La misión del Instituto es impulsar una investigación fundamental, colaborativa y audaz que aborde los retos más acuciantes de la sociedad, entre ellos el cáncer, la enfermedad de Alzheimer y la vulnerabilidad agrícola. Esta ciencia fundamental sustenta todos los esfuerzos traslacionales, generando conocimientos que permiten el desarrollo de nuevos medicamentos e innovaciones en todo el mundo.